Plant-Based Biofactories
Plant-based biofactories leverage the inherent capabilities of plants to produce valuable biomolecules, including pharmaceuticals, vaccines, and biofuels. These biofactories utilize genetic engineering techniques to enhance the production of specific compounds within plant tissues, optimizing growth conditions and metabolic pathways. The advantage of using plants lies in their ability to produce complex proteins with post-translational modifications similar to those in human cells, making them suitable for therapeutic applications. Moreover, plant biofactories are environmentally sustainable, offering a cost-effective alternative to traditional microbial or animal cell culture systems. Continued research is focused on improving yield and efficiency, thus enabling wider application of this innovative approach in biomanufacturing.
Srinivasa Rao Mentreddy
Alabama A&M University, United States
Mohammad Babadoost
University of Illinois, United States
Valasia Iakovoglou
UNESCO chair Con-E-Ect, International Hellenic University, Greece
Aparna B Gunjal
Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce
Bethune-Cookman University, United States
Hillary Jean Pierre
Department of Pharmaceutics, United States
Title : Biovalorization of overripe banana (Musa spp.) extract as a functional ingredient for glycemic regulation in diabesity management
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title :
Valasia Iakovoglou, UNESCO chair Con-E-Ect, International Hellenic University, Greece
Title : The antimicrobial activity of six Ocimum species against human microbial pathogens
Srinivasa Rao Mentreddy, Alabama A&M University, United States
Title : Effect of climate and weather on plant biology and biotechnology
Vijayan Gurumurthy Iyer, Techno-Economic-Environmental Study and Check Consultancy Services, India
Title : Cambial rearrangement in cycads: First evidence from a basal seed plant lineage
Anna Ponce, Bethune-Cookman University, United States
Title : Utilizing plant derived extracellular vesicles for drug delivery and therapeutic development
Hillary Jean Pierre, Department of Pharmaceutics, United States